Radiology · 1996 · 90 citations · 0 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyPulmonologyMagnetic Resonance Contrast MechanismsMagnetic Resonance ImagingMedical ImagingPulmonary ImagingPulmonary Nodule EvaluationPulmonary Parenchymal ImagingContrast EnhancementContrast Enhancement PatternsGradient Echo SequencesMagnetic ResonanceParamagnetic Contrast AgentsParenchymal Enhancement PatternsPulmonary Nodule DiagnosisSolitary Pulmonary Nodule Assessment
PURPOSE: To evaluate the enhancement patterns of solitary pulmonary nodules (SPNs) with dynamic contrast-material-enhanced magnetic resonance (MR) imaging to differentiate between benign and malignant SPNs. MATERIALS AND METHODS: Twenty-eight patients with SPNs 30 mm or smaller in diameter were examined with pre- and postcontrast, electrocardiographically gated, T1-weighted spin-echo (SE) sequences and a snapshot gradient-echo (GRE) sequence after bolus injection of a paramagnetic contrast agent. For all SPNs (20 malignant, eight benign), the percentage increase in signal intensity (%SI) on the postcontrast T1-weighted SE images and the enhancement curves (%SI/sec) for the snapshot GRE measurements were established from regions of interest. RESULTS: Malignant nodules showed a higher increase of signal intensity during the first transit of the bolus of contrast material on the dynamic snapshot GRE images (malignant: median, 18.1 %SI/sec; range, 6.7-95.2 %SI/sec; benign: median, 2.3 %SI/sec; range, 0.1-8.1 %SI/sec) (P < .0001). Static T1-weighted SE measurements did not allow differentiation between malignant (median, 53.4 %SI; range 12.5-110.0 %SI) and benign (median, 33 %SI; range, 0.8-85.5 %SI) (P > .2) nodules on the basis of the degree of contrast enhancement. CONCLUSION: Dynamic contrast-enhanced MR measurements of tumor enhancement can provide additional information about the nature of SPNs.